Medical School

Pulmonary, Allergy, Critical Care and Sleep Medicine

Department of Medicine

Pulmonary, Allergy, Critical Care and Sleep Medicine

MEDDOM2 PACCS Main page Image 700x190 blue lungs

For Patients  |  Conferences  |  Contact Us

The Division of Pulmonary, Allergy, Critical Care and Sleep Medicine (PACCS) encompasses all facets of medicine that relate to lung science. Over 30 faculty are employed in this division providing broad expertise, a diverse clinical practice, and fellowship training at four hospitals.

With generous support from the NIH, VA Research Service, American Lung Association, Cystic Fibrosis Foundation and several other private foundations, we are committed to providing our students the best graduate and postgraduate education in lung science available today.

PACCS proudly features internationally-recognized programs in Critical Care Medicine, Advanced Lung Disease and Lung Transplantation, Chronic Obstructive Pulmonary Disease , Physiology of Mechanical Ventilation, Genetics of Asthma, Fungal Infections, and Sleep-disordered Breathing.

The division is expanding with major new investments from the Medical School and Academic Health Center. Training is offered in Lung Cell and Molecular Biology, Bioengineering and Clinical Trials, with joint Masters and PhD programs.

We strive to find cures for Acute Lung Injury, Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease, Pulmonary Hypertension and other deadly lung diseases as we continuously improve current preventive strategies and treatment modalities.

Medical Research Funding Alert

MEDDOM2 PACCS Test TubesPulmonary Fibrosis is a chronic and lethal disease that takes the life of an American every 13 minutes. Few treatments are available to combat this disease. In the division of Pulmonary Medicine, we have a long standing active research program that seeks to understand the pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) at the basic science level. Funding from the NIH has decreased over the past few years due to legislation funding policies. The impact of these policies has affected medical research profoundly which in turn is slowing progress in medical breakthroughs like pulmonary fibrosis. This affects you and millions of Americans. Take 5 minutes to review the Pulmonary Fibrosis Advocates challenge information sheet and contact your Senator and Representative to advocate for increased funding for medical research.

  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on March 25, 2015